The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Osteosarcoma, Chondrosarcoma, and Chordoma
Abstract
Osteosarcoma (OS), chondrosarcoma, and chordoma are characterized by multiple challenges to the investigator, clinician, and patient. One consequence of their rarity among sarcomas, as well as their biologic and clinical heterogeneity, is that management guidelines are inadequate to inform the range of individual patient-treatment decisions from diagnosis, approaches to surgery, chemotherapy, radiotherapy, treatment of recurrence, palliative care, and quality of survivorship. Of high-grade sarcomas, OSs are among the most curable, with more than two-thirds of patients with localized disease likely to achieve long-term survival. Neoadjuvant chemotherapy comprising cisplatin, doxorubicin, and methotrexate with intercalated surgery is the standard of care for resectable OS in those younger than 40 years. Outcomes for OS presenting with unresectable metastases or recurrent disease, or in those older than 40 years are generally poor. Overall results have improved little for all patients with OS, and new treatments are needed. Surgical resection remains the cornerstone of management for chondrosarcoma and chordoma. However, the application of new biologic insights to therapeutic development indicates that improved treatments may soon be routine for patients with chondrosarcoma and chordoma for whom surgery alone is inadequate. For all these uncommon diseases, patients should be offered specialist expert care delivered by experienced multidisciplinary teams in high-volume centers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO classification of tumours of soft tissue and bone
Fletcher, C. D. �. (2013) · Cited by 2,874
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
Amary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24320 · Cited by 791
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Burningham, Z., Hashibe, M., Spector, L., & Schiffman, J. D. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-14 · Cited by 639
Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., Hook, J. M., Arndt, C., van den Berg, H., Brennan, B., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30214-5 · Cited by 551
Self-citationBuddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2047 · Cited by 508
Stacchiotti, S., & Sommer, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71190-8 · Cited by 501
Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0734 · Cited by 422
Self-citationRosen, G., Murphy, M. L., Huvos, A. G., Gutierrez, M., & Marcove, R. C. (1976) · Cancer · doi:10.1002/1097-0142(197601)37:1<1::aid-cncr2820370102>3.0.co;2-3 · Cited by 353
Grignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 340
Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu526 · Cited by 333
Self-citationPostrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316
Koirala, P., Roth, M. E., Gill, J., Piperdi, S., Chinai, J. M., Geller, D. S., Hoang, B. H., Park, A., Fremed, M. A., Zang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30093 · Cited by 267
Behjati, S., Tarpey, P. S., Haase, K., Ye, H., Young, M. D., Alexandrov, L. B., Farndon, S. J., Collord, G., Wedge, D. C., Martincorena, I., et al. (2017) · Nature Communications · doi:10.1038/ncomms15936 · Cited by 261
Incidence and survival of malignant bone sarcomas in England 1979–2007
Whelan, J., McTiernan, A., Cooper, N., Wong, Y. K., Francis, M., Vernon, S., & Strauss, S. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.26426 · Cited by 255
Self-citationStacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx054 · Cited by 241
Smeele, L. E., Kostense, P. J., van der Waal, I., & Snow, G. B. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.363 · Cited by 193
Lagmay, J. P., Krailo, M. D., Dang, H., Kim, A., Hawkins, D. S., Beaty, O., Widemann, B. C., Zwerdling, T., Bomgaars, L., Langevin, A.-M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.5381 · Cited by 190
Osteosarcoma over the age of forty
Grimer, R. J., Cannon, S. R., Taminiau, A. M., Bielack, S., Kempf-Bielack, B., Windhager, R., Dominkus, M., Saeter, G., Bauer, H., Meller, I., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00478-1 · Cited by 188
Collins, M., Wilhelm, M., Conyers, R., Herschtal, A., Whelan, J., Bielack, S., Kager, L., Kühne, T., Sydes, M., Gelderblom, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.8598 · Cited by 187
Self-citationTreatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
Harris, M. B., Gieser, P., Goorin, A. M., Ayala, A., Shochat, S. J., Ferguson, W. S., Holbrook, T., & Link, M. P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3641 · Cited by 185
Janeway, K. A., Barkauskas, D. A., Krailo, M. D., Meyers, P. A., Schwartz, C. L., Ebb, D. H., Seibel, N. L., Grier, H. E., Gorlick, R., & Marina, N. (2012) · Cancer · doi:10.1002/cncr.27414 · Cited by 179
Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
Khanna, C., Fan, T. M., Gorlick, R., Helman, L. J., Kleinerman, E. S., Adamson, P. C., Houghton, P. J., Tap, W. D., Welch, D. R., Steeg, P. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2574 · Cited by 178
Frezza, A. M., Cesari, M., Baumhoer, D., Biau, D., Bielack, S., Campanacci, D. A., Casanova, J., Esler, C., Ferrari, S., Funovics, P. T., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.11.007 · Cited by 176
Self-citationHeery, C. R., Singh, B. H., Rauckhorst, M., Marté, J. L., Donahue, R. N., Grenga, I., Rodell, T. C., Dahut, W. L., Arlen, P. M., Madan, R. A., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0119 · Cited by 143
Gelderblom, H. A. J., Jinks, R. C., Sydes, M. R., Bramwell, V. H. C., Glabbeke, M. M. V., Grimer, R. J., Hogendoorn, P. C. W., McTiernan, A., Lewis, I. J., Nooij, M. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.036 · Cited by 136
Self-citationJasnau, S., Meyer, U., Potratz, J. C., Jundt, G., Kevric, M., Joos, U., Jürgens, H., & Bielack, S. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.03.001 · Cited by 129
Proton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers
Leroy, R., Benahmed, N., Hulstaert, F., Damme, N. V., & Ruysscher, D. D. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.10.025 · Cited by 122
Extraosseous Osteosarcoma: Response to Treatment and Long-Term Outcome
Ahmad, S., Patel, S. R., Ballo, M. T., Baker, T. P., Yasko, A. W., Wang, X., Feig, B. W., Hunt, K. K., Lin, P. P., Weber, K. L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.2.521 · Cited by 114
Sundara, Y. T., Kostine, M., Cleven, A. H. G., Bovée, J. V. M. G., Schilham, M. W., & Cleton-Jansen, A.-M. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1925-3 · Cited by 111
Periosteal osteosarcoma – a European review of outcome
Grimer, R. J., Bielack, S., Flege, S., Cannon, S. R., Foleras, G., Andreeff, I., Sokolov, T., Taminiau, A., Dominkus, M., San-Julian, M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.052 · Cited by 110
Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma
Goldstein-Jackson, S. Y., Gosheger, G., Delling, G., Berdel, W. E., Exner, G. U., Jundt, G., Machatschek, J.-N., Zoubek, A., Jürgens, H., Bielack, S., et al. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0687-7 · Cited by 107
Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., Fagioli, F., Asaftei, S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2312-3 · Cited by 98
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients
Longhi, A., Bielack, S., Grimer, R. J., Whelan, J. S., Windhager, R. H., Leithner, A., Gronchi, A., Biau, D. J., Jutte, P. C., Krieg, A. H., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.016 · Cited by 94
Self-citationBramwell, V. H. C., Steward, W. P., Nooij, M. A., Whelan, J. S., Craft, A. W., Grimer, R. J., Taminau, A. H. M., Cannon, S. R., Malcolm, A. J., Hogendoorn, P. C. W., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3260 · Cited by 89
Self-citationArndt, C. A. S., Koshkina, N., Inwards, C. Y., Hawkins, D. S., Krailo, M., Villaluna, D., Anderson, P. M., Goorin, A. M., Blakely, M. L., Bernstein, M. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0662 · Cited by 87
Periosteal osteosarcoma: A single‐institution experience
Cesari, M., Alberghini, M., Vanel, D., Palmerini, E., Staals, E. L., Longhi, A., Abate, M. E., Ferrari, C., Balladelli, A., & Ferrari, S. M. (2010) · Cancer · doi:10.1002/cncr.25718 · Cited by 78
The Evolving Role of Proton Beam Therapy for Sarcomas
Frisch, S., & Timmermann, B. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.04.034 · Cited by 78
Iwata, S., Ishii, T., Kawai, A., Hiruma, T., Yonemoto, T., Kamoda, H., Asano, N., & Takeyama, M. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3210-4 · Cited by 72
Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohort
Mahajan, A., Woo, S. Y., Kornguth, D. G., Hughes, D. P. M., Huh, W. W., Chang, E. L., Herzog, C. E., Pelloski, C. E., & Anderson, P. M. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21451 · Cited by 68
Chou, A. J., Gupta, R., Bell, M. D., O’Day, K., Meyers, P. A., & Gorlick, R. G. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24438 · Cited by 68
Nooij, M. A., Whelan, J. S., Bramwell, V. H. C., Taminiau, A. T., Cannon, S. R., Hogendoorn, P. C. W., Pringle, J. A. S., Uscinska, B., Weeden, S., Kirkpatrick, A., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.026 · Cited by 60
Self-citationLebellec, L., Chauffert, B., Blay, J., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.037 · Cited by 56
Pulmonary Metastasectomy for Osteosarcoma: Is It Justified?
Diemel, K., Klippe, H. J., & Branscheid, D. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-77960-5_12 · Cited by 33
Alpha Emitter Radium 223 in High-Risk Osteosarcoma
Subbiah, V., Anderson, P. M., & ROHREN, E. M. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.289 · Cited by 30
Pulmonary metastasetomy for osteosarcoma: is it justified?
Diemel, K., Klippe, H. J., & Branseheid, D. (2009) · PubMed · Cited by 24
Frezza, A. M., Beale, T., Bomanji, J. B., Jay, A., Kalavrezos, N., Dileo, P., Whelan, J. S., & Strauss, S. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-23 · Cited by 21
Self-citationPakos, E. E., Grimer, R. J., Peake, D., Spooner, D. A., Carter, S. R., Tillman, R. M., Abudu, S., & Jeys, L. M. (2011) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.93b9.27166 · Cited by 20
Cited by
Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy310 · Cited by 617
Self-citationCurrent advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., Bonvalot, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.08.1995 · Cited by 513
Sarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02374 · Cited by 268
Self-citation
Metadata
- Authors
- Whelan, J. S., & Davis, L. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2018-01-10
- Volume
- 36
- Issue
- 2
- Pages
- 188-193
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2773653224
- Cited by
- 479
- References
- 54
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.